✦ LIBER ✦

Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004–2008)

✍ Scribed by G. Young; D. L. Cooper; R. Z. Gut; on behalf of the HTRS Investigators

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exposure and safety of higher doses of r

✍ E. J. NEUFELD; C. M. KESSLER; J. C. GILL; C. T. WILKE; D. L. COOPER; ON BEHALF O 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Recombinant activated factor VII safety

✍ C. NAKAR; D. L. COOPER; D. DiMICHELE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Dose effect and efficacy of rFVIIa in th

✍ R. Parameswaran; A. D. Shapiro; J. C. Gill; C. M. Kessler; HTRS Registry Investi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Single-dose (270 μg kg−1) recombinant ac

✍ B. PAN-PETESCH; P. LAGUNA; A. MITAL; J. STANLEY; M. F. TORCHET; S. Z. SALEK; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB